Improvement of four patients with HIV-1 related symptoms after hyperimmunization with killed poliomyelitis (Salk) vaccine.
Four HIV-1 positive patients with characteristic symptoms of this infection experienced amelioration or resolution of symptoms after 2 months of hyperimmunization with inactivated (Salk) poliomyelitis vaccine. The patient who was initially the most symptomatic exhibited a marked improvement in T4/T8 ratio at the sixth month of continued hyperimmunization treatment. With two patients reported previously, six consecutive patients with lymphotropic retrovirus disease have benefited from hyperimmunization with inactivated polio vaccine.
Pitts
F N
FN
Allen
R E
RE
Haraszti
J S
JS
Allen
A D
AD
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D000328:Adult; D005069:Evaluation Studies as Topic; D006801:Humans; D008297:Male; D008875:Middle Aged; D011054:Poliovirus Vaccine, Inactivated / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000145:classification
D011054:Poliovirus Vaccine, Inactivated